These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 119888)

  • 1. Synthetic rates of monoamine oxidase in rat liver after clorglyine or deprenyl administration.
    Egashira T; Kamijo K
    Jpn J Pharmacol; 1979 Aug; 29(4):677-80. PubMed ID: 119888
    [No Abstract]   [Full Text] [Related]  

  • 2. The reaction of bovine and rat liver monoamine oxidase with [14C]-clorgyline and [14C]-deprenyl.
    Salach JI; Detmer K; Youdim MB
    Mol Pharmacol; 1979 Jul; 16(1):234-41. PubMed ID: 481419
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
    Zsilla G; Földi P; Held G; Székely AM; Knoll J
    Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations.
    Lai JC; Leung TK; Guest JF; Lim L; Davison AN
    Biochem Pharmacol; 1980 Oct; 29(20):2763-7. PubMed ID: 6776961
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of selective monoamine oxidase inhibitors, clorgyline and deprenyl, upon tissue glycogen stores and blood glucose levels.
    Ismahan G; Parvez H; Parvez S; Youdim MB
    J Neural Transm Suppl; 1978; (14):143-52. PubMed ID: 290735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG; Vizi ES
    Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique.
    Kitahama K; Arai R; Maeda T; Jouvet M
    Neurosci Lett; 1986 Oct; 71(1):19-24. PubMed ID: 3097589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environments.
    Houslay MD
    J Pharm Pharmacol; 1977 Nov; 29(11):664-9. PubMed ID: 22599
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
    Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
    J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
    Sandler M; Glover V; Ashford A; Esmail A
    J Neural Transm; 1980; 48(4):241-7. PubMed ID: 6775051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.